Evaluation of Single Dose and Steady State Pharmacokinetics of Flibanserin Postmenopausal Women With Hypoactive Sexual Desire Disorder
Phase of Trial: Phase I
Latest Information Update: 04 Jul 2014
At a glance
- Drugs Flibanserin (Primary)
- Indications Decreased libido
- Focus Pharmacokinetics
- Sponsors Sprout Pharmaceuticals
- 09 Apr 2012 Company (Sprout Pharmaceuticals) added as trial sponsor as reported by ClinicalTrials.gov.
- 15 Nov 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Oct 2010 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.